Infection by optic pathogens such as Pneumocystis carinii (Pc) constitute the major fatal consequence of Human Immunodeficiency Virus HIV-induced Acquired Immunodeficiency Syndrome (AIDS). Since the number of disposed AIDS patients continues to increase worldwide, these opportunistic infections represent major and increasing public health challenges. The basic biology and genetics of the host-opportunistic pathogen interaction are not yet well understood, however. Moreover, restoration of immune function to an immunocompromised individual presents opportunities for either successful resolution of opportunistic infections or for inflammatory reactions themselves fatal to the host. With new drugs being developed to hold HIV and opportunistic infections temporarily at bay, and with hope of an eventual cure of HIV through molecular genetics, increasing numbers of patients will be faced with the challenge of reestablishing complete immune function and returning to normal life. This project will continue to utilize several genetically-defined mouse models to pursue the etiology, genetics, and therapy of Pc, via investigation of the following specific questions: 1) What are the effector mechanisms in pathogenesis from and immunity to Pc, and how can we provide protective or curative immunity with a minimum of harmful consequences? Previously developed cellular and humoral immunological reagents will be used to address these issues. 2) Which other microbial agents pathologically synergize with Pc, what are the mechanisms for such synergy, and how can we utilize the answers to these questions to choose the best targets and routes for therapy in cases of multiple infections? 3) What am the molecular and genetic determinants of Pc infectivity? Previously generated antibody and T cell reagents will be used to clone the gene and investigate the biology of the major antigenic protein of Pc, and to investigate the possible occurrence and relevance of Pc substrains. Standard genetic crosses will be used to reveal the genetic variables affecting host susceptibility to Pc.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025765-05
Application #
3139341
Study Section
Special Emphasis Panel (ARR (V1))
Project Start
1987-09-15
Project End
1992-01-31
Budget Start
1991-09-01
Budget End
1992-01-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Haas, David W; Wu, Hulin; Li, Haihong et al. (2003) MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study. J Acquir Immune Defic Syndr 34:295-8
Prasad, V S; Temple, M J; Davisson, M T et al. (1996) Heterogeneity of B-lymphoid tumors in E mu-myc transgenic mice. Cytometry 23:131-9
Sidman, C L; Shaffer, D J (1994) Large-scale genomic comparison using two-dimensional DNA gels. Genomics 23:15-22
Jacobsen, K A; Prasad, V S; Sidman, C L et al. (1994) Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice. Blood 84:2784-94
Allen, R D; Staley, T A; Sidman, C L (1993) Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 23:333-7
Bray, M V; Barthold, S W; Sidman, C L et al. (1993) Exacerbation of Pneumocystis carinii pneumonia in immunodeficient (scid) mice by concurrent infection with a pneumovirus. Infect Immun 61:1586-8
Roths, J B; Smith, A L; Sidman, C L (1993) Lethal exacerbation of Pneumocystis carinii pneumonia in severe combined immunodeficiency mice after infection by pneumonia virus of mice. J Exp Med 177:1193-8
Sidman, C L; Denial, T M; Marshall, J D et al. (1993) Multiple mechanisms of tumorigenesis in E mu-myc transgenic mice. Cancer Res 53:1665-9
Lynes, M A; Tibbetts, D J; Swenson, L M et al. (1993) Dynamic associations of CD45 and Thy-1 on plasma membranes of C3H-gld/gld and C3H-lpr/lpr. I. Potential effects on proliferation and phosphatase activity. Cell Immunol 151:65-79
Roths, J B; Sidman, C L (1993) Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect Immun 61:1641-9

Showing the most recent 10 out of 23 publications